DLB: Dolby Laboratories, Inc. Stock

SIC 6794 – Patent Owners and Lessors

Valuation
Market Cap ($M) 4,417.28
Enterprise Value ($M) 3,690.23
Book Value ($M) 2,447.43
Book Value / Share 41.01
Price / Book 1.80
NCAV ($M) 942.45
NCAV / Share 15.79
Price / NCAV 4.69

Profitability (mra)
Return on Invested Capital (ROIC) 0.09
Return on Assets (ROA) 0.07
Return on Equity (ROE) 0.09

Liquidity (mrq)
Quick Ratio 4.04
Current Ratio 4.14

Balance Sheet (mrq) ($M)
Current Assets 1,468.65
Assets 2,973.64
Liabilities 526.20
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
09-10 13G/A Morgan Stanley 11.80 53.35
02-13 13G/A Vanguard Group Inc 10.80 6.36
02-13 13G/A Kayne Anderson Rudnick Investment Management Llc 9.19 6.07
01-24 13G/A BlackRock Inc. 9.80 85.96

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 28, 2024 ☐ TRANSITION REPORT PURSUANT TO S
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 29, 2024 ☐ TRANSITION REPORT PURSUANT TO
2024-02-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 29, 2023 ☐ TRANSITION REPORT PURSUANT
2023-11-17 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended September 29, 2023 ☐ TRANSITION REPORT PURSUANT TO SECT

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-10-17 54,181 197,584 27.42
2024-10-16 45,334 222,764 20.35
2024-10-15 45,462 227,137 20.02
2024-10-14 53,160 213,514 24.90

(click for more detail)

Similar Companies
CXW – CoreCivic, Inc. DEA – Easterly Government Properties, Inc.
DEI – Douglas Emmett, Inc. DLR – Digital Realty Trust, Inc.
DOC – Healthpeak Properties, Inc.


Financial data and stock pages provided by
Fintel.io